Effects of Acute and Chronic Graft-versus-myelodysplastic Syndrome on Long-term Outcomes Following Allogeneic Hematopoietic Cell Transplantation.
Takaaki KonumaKen IshiyamaAiko IgarashiNaoyuki UchidaYukiyasu OzawaTakahiro FukudaYasunori UedaKen-Ichi MatsuokaTakehiko MoriYuta KatayamaMakoto OnizukaTatsuo IchinoheYoshiko Atsutanull nullPublished in: Clinical cancer research : an official journal of the American Association for Cancer Research (2020)
These data demonstrated a survival benefit of the graft-versus-MDS effect is present only in high-risk MDS patients with limited chronic GVHD.See related commentary by Eckel and Deeg, p. 6404.